Leading the Way in Life Science Technologies

GEN Exclusives

More »

Sickle Cell Disease - Related Content

  • Page 1 of 1 (1 items) 1 
  • Insight & Intelligence™
  • Blood Flow as Diagnostic Marker
    August 17, 2012

    Jamming, or vaso-occlusion, could be used to distinguish sickle cell disease patients with poor outcomes from those with good outcomes.
  • Page 1 of 1 (1 items) 1 

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »